Skip to main content
●+254 119 023975 support@dnalabskenya.com
Patient Portal LoginB2B / Doctor Portal
DNA LabsKenya
Medical information Clinical review pending

Gastroenterology Testing

Asca Anti Saccharomyces Cerevisiae Antibody Panel IgA IgG Test

The Asca Anti Saccharomyces Cerevisiae Antibody Panel IgA IgG Test helps identify antibodies related to inflammatory bowel diseases like Crohn's disease. It aids in the diagnosis and management of gastrointestinal disorders.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2 mL (1 mL minimum) serum collected in an SST tube.
Results
Report available same day if the sample is received by Thursday 9 AM. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test.
Test priceKSh 5,850

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Asca Anti Saccharomyces Cerevisiae Antibody Panel IgA IgG Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us
01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Persistent abdominal pain
  • ✓Chronic diarrhea
  • ✓Unexplained weight loss
  • ✓Fatigue associated with digestive issues
  • ✓Family history of inflammatory bowel disease
  • ✓Evaluation of suspected Crohn's disease
02

In plain language

What this test helps you understand

This test aids in the diagnostic workup of inflammatory bowel disease (IBD), particularly Crohn's disease, by detecting antibodies against Saccharomyces cerevisiae. It can help differentiate between Crohn's disease and ulcerative colitis, and may assist in monitoring disease activity or response to treatment.
The Asca Anti Saccharomyces Cerevisiae Antibody Panel IgA IgG Test is a diagnostic tool used to detect antibodies against Saccharomyces cerevisiae, a type of yeast. The presence of these antibodies, particularly IgA and IgG types, can be associated with inflammatory bowel diseases (IBD), such as Crohn's disease. This test provides valuable information to healthcare providers for diagnosing and managing gastrointestinal conditions. It measures the levels of specific antibodies in your serum (blood). Elevated levels may suggest an increased likelihood of IBD, guiding further diagnostic steps and treatment strategies. This test is often recommended for individuals experiencing persistent gastrointestinal symptoms or those with a family history of IBD.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test.
Sample2 mL (1 mL minimum) serum collected in an SST tube.
MethodologyEnzyme Immunoassay (EIA).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test is not definitive for diagnosing IBD and should be used alongside other diagnostic methods. Results must be interpreted in the context of the patient's clinical presentation and other test results. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects IgA and IgG antibodies against Saccharomyces cerevisiae, a yeast, which can be associated with inflammatory bowel diseases like Crohn's disease.
Individuals experiencing symptoms like chronic diarrhea, abdominal pain, unexplained weight loss, or fatigue, especially those with a family history of IBD, may be advised to take this test.
A blood sample (serum) is required for this test. Typically, 2 mL of serum is needed, collected in an SST tube.
No special preparation is required for this test.
Results are typically available the same day if the sample is received by Thursday 9 AM. Confirm with the laboratory before booking.
Your doctor will interpret the results in the context of your symptoms and other tests. A positive result may indicate a higher likelihood of IBD and may require further investigation.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Helicobacter Pylori Antigen Rapid Stool Test

A non-invasive stool test to detect Helicobacter Pylori (H. Pylori) bacteria, which can cause digestive issues like gastritis and ulcers. Confirm with the laboratory before booking.

Learn more →

Giardia Antigen Test Rapid Stool Test

A rapid stool test to detect Giardia lamblia antigens, helping diagnose gastrointestinal infections causing symptoms like diarrhea and abdominal pain.

Learn more →

5-Aminolevulinic Acid 5 ALA Random Urine Test

The 5-Aminolevulinic Acid (5 ALA) Random Urine Test helps diagnose porphyrias, disorders affecting heme production. This test measures 5 ALA levels in urine to identify potential metabolic issues.

Learn more →

5-Aminolevulinic Acid (5 ALA) 24 Hour Urine Test

The 5-Aminolevulinic Acid (5 ALA) 24 Hour Urine Test helps diagnose porphyrias, a group of rare metabolic disorders. This test measures 5-ALA levels in urine collected over 24 hours.

Learn more →
Chat on WhatsApp